BlackRock Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$244K Sell
28,528
-438
-2% -$3.75K ﹤0.01% 2616
2016
Q3
$238K Buy
28,966
+2,956
+11% +$24.8K ﹤0.01% 2592
2016
Q2
$209K Sell
26,010
-169
-0.6% -$1.35K ﹤0.01% 2580
2016
Q1
$176K Buy
26,179
+1,650
+7% +$10.9K ﹤0.01% 2630
2015
Q4
$193K Sell
24,529
-10,907
-31% -$79.9K ﹤0.01% 2590
2015
Q3
$203K Buy
35,436
+2,047
+6% +$12.7K ﹤0.01% 2716
2015
Q2
$181K Buy
33,389
+30,650
+1,119% +$158K ﹤0.01% 2847
2015
Q1
$13K Hold
2,739
﹤0.01% 3509
2014
Q4
$11K Buy
+2,739
New +$12.6K ﹤0.01% 3596
2014
Q2
Sell
-21,444
Closed -$74K 3703
2014
Q1
$74K Buy
21,444
+1,169
+6% +$4.38K ﹤0.01% 3148
2013
Q4
$73K Buy
20,275
+5,083
+33% +$17.6K ﹤0.01% 3157
2013
Q3
$46K Buy
15,192
+569
+4% +$1.6K ﹤0.01% 3210
2013
Q2
$58K Buy
+14,623
New +$55.8K ﹤0.01% 3130

Other funds holding NEO

BlackRock Advisors's NEO Position: Q4 2016 in Review

BlackRock Advisors reduced its NeoGenomics (NEO) stake by 1.5% in Q4 2016, selling an estimated $3.75K and leaving 28,528 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #2616.

BlackRock Advisors first reported a position in NEO in Q2 2013 and has held it in 13 quarters since. 143 funds tracked by Wall St. Rank hold NEO as of Q4 2016.

  • BlackRock Advisors held 28,528 shares of NeoGenomics worth $244K as of Q4 2016.
  • BlackRock Advisors sold 438 NeoGenomics shares in Q4 2016, an estimated $3.75K.
  • NeoGenomics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2616 holding.
  • BlackRock Advisors first reported a position in NeoGenomics in Q2 2013 and has held it in 13 quarters since.
  • 143 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.